Literature DB >> 25086370

Oral administration of Nitraria retusa ethanolic extract enhances hepatic lipid metabolism in db/db mice model 'BKS.Cg-Dock7(m)+/+ Lepr(db/)J' through the modulation of lipogenesis-lipolysis balance.

Feten Zar Kalai1, Junkyu Han2, Riadh Ksouri3, Chedly Abdelly3, Hiroko Isoda4.   

Abstract

The medicinal plants can be used in the prevention or treatment of many diseases. Several studies concerning the potential of bioactive components in plants and food products and their link to obesity and related metabolic disorders, have been gaining big interest. Diabetes is a serious metabolic syndrome. Searching for alternative natural bioactive molecules is considered main strategy to manage diabetes through weight management. In the present study, an edible halophyte Nitraria retusa was selected and in vivo experiment was conducted using db/db model mice. We orally administrated its ethanol extract (NRE) to BKS.Cg-Dock7(m)+/+ Lepr(db/)J mice model for a period of 4 weeks. The effect was evaluated on the body weight and adiposity changes and on the biochemical parameters of db/db NRE-treated mice. The molecular mechanism underlying the anti-obesity effect was investigated by testing the gene expression related to hepatic lipid metabolism. NRE was found to significantly supress increases in body and fat mass weight, decreases triglycerides and LDL-cholesterol levels and enhances gene expression related to lipid homeostasis in liver showing anti-obesity actions. Our findings, indicate that NRE possesses potential anti-obesity effects in BKS.Cg-Dock7(m)+/+ Lepr(db/)J model mice and may relieve obesity-related symptoms including hyperlipidemia through modulating the lipolysis-lipogenesis balance.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BKS.Cg-Dock7(m)+/+ Lepr(db/)J mice; Diabetes; Lipid metabolism; Liver; Nitraria retusa

Mesh:

Substances:

Year:  2014        PMID: 25086370     DOI: 10.1016/j.fct.2014.07.029

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice.

Authors:  Jiawei Lv; Kai Zhuang; Xiyu Jiang; Heqing Huang; Shijian Quan
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-28       Impact factor: 3.168

2.  Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis.

Authors:  Munkhzul Ganbold; Yohei Owada; Yusuke Ozawa; Yasuhiro Shimamoto; Farhana Ferdousi; Kenichi Tominaga; Yun-Wen Zheng; Nobuhiro Ohkohchi; Hiroko Isoda
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

3.  Xiaokeping Mixture Attenuates Diabetic Kidney Disease by Modulating TGF-β/Smad Pathway in db/db Mice.

Authors:  Bo Yang; Zhongni Xia; Chuanwei Xin; Chenggang Ma; Feng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-08       Impact factor: 2.629

4.  Antiobesity Effects of Extract from Spergularia marina Griseb in Adipocytes and High-Fat Diet-Induced Obese Rats.

Authors:  Yong-Hyun Park; Jae-Joon Lee; Hee-Kyoung Son; Bok-Hee Kim; Jaemin Byun; Jung-Heun Ha
Journal:  Nutrients       Date:  2020-01-27       Impact factor: 5.717

5.  Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice.

Authors:  Lawrence Mabasa; Anri Kotze; Samukelisiwe Shabalala; Clare Kimani; Kwazi Gabuza; Rabia Johnson; Nonhlakanipho F Sangweni; Vinesh Maharaj; Christo J F Muller
Journal:  Int J Environ Res Public Health       Date:  2022-03-22       Impact factor: 3.390

Review 6.  The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism.

Authors:  Sha Li; Yu Xu; Wei Guo; Feiyu Chen; Cheng Zhang; Hor Yue Tan; Ning Wang; Yibin Feng
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

Review 7.  Effects of Isorhamnetin on Diabetes and Its Associated Complications: A Review of In Vitro and In Vivo Studies and a Post Hoc Transcriptome Analysis of Involved Molecular Pathways.

Authors:  Feten Zar Kalai; Mondher Boulaaba; Farhana Ferdousi; Hiroko Isoda
Journal:  Int J Mol Sci       Date:  2022-01-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.